A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 1149-1154

  Peng, Stanford L ^a   Robert, Marie E ^a   Mayday, Adrian C ^a   Craft, Joe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN M;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CANCER INHIBITION; CELL DEATH; CELL FUNCTION; CELL HYPERPLASIA; CHROMOSOME 10Q; LIGAND BINDING; LYMPHOMA; MALIGNANT TRANSFORMATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029809754     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.1149     Document Type: Article

References (29)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
2. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
3. Fisher, G.H., FJ. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, MJ. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:935-946.
4. Renno, T., M. Hahne, J. Tschopp, and H.R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express D220 and upregulate Fas and Fas ligandj. Exp. Med. 183:431-437.
5. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:321-328.
6. Rathmell, J.C., M.P. Cooke, W.Y. Ho, J. Grein, S.E. Townsend, M.M. Davis, and C.C. Goodnow. 1995. CD95 (Fas)-dependent elimination of self-reactive D cells upon interaction with CD4+ T cells. Nature (Lend.). 376:181-184.
7. Rothstein, T.L., J.K. Wang, DJ. Panka, L.C. Foote, Z. Wang, B. Stanger, H. Cui, S.T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th 1-mediated apoptosis by antigen receptor engagement in D cells. Nature (Loud.). 374:163-165.
8. Kondo, E., T. Yoshino, I. Yamadori, Y. Matsuo, N. Kawasaki, J. Minowada, and T. Akagi. 1994. Expression ofBcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am. J. Pathol. 145:330-337.
9. Lichter, P., H. Walczak, S. Weitz, I. Behnmnn, and P.H. Krammer. 1992. The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. Gciiomics. 14:179-180.
10. Gray, I.C., S.M. Phillips, SJ. Lee, J.P. Neoptolemos, J. Weissenbach, and N.K. Spurr. 1995. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55:4800-4803.
11. Simon, M., A. von Deimling, J J. Larson, R. Wellenreuther, P. Kaskel, A. Waha, R.E. Warnick, J.M. Tew, Jr., and A.G. Menon. 1995. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res. 55:4696-4701.
12. Herbst, R.A., J. Weiss, A. Ehnis, W.K. Cavenee, and K.C. Arden. 1994. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 54:3111-3114.
13. Peiffer, S.L., TJ. Herzog, DJ. Tribune, D.G. Mutch, DJ. Gersell, and PJ. Goodfellow. 1995. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 55:1922-1926.
14. Speaks, S.L., W.G. Sanger, A.S. Masih, D.S. Harrington, M. Hess, and J.O. Armitage. 1992. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chrom. Cancer. 5:239-243.
15. Morse, H.C. HI, W.F. Davidson, R.A. Yetter, E.D. Murphy, J.B. Roths, and R.L. Coffman. 1982. Abnormalities induced by the mutant gene Ipr. expansion of a unique lymphocyte subset. J. Imimmol. 129:2612-2615.
16. Senju, S., I. Negishi, N. Motoyama, F. Wang, K. Nakayama, K. Nakayama, PJ. Lucas, S. Hatakeyama, Q. Zhang, S. Yonehara, and D.Y. Loh. 1995. Functional significance of the Fas molecule in naive lymphocytes. Int. Iniiniinol. 8:423-131.
17. Morse, H.C. III.J.B. Roths, W.F. Davidson, W.Y. Langdon, T.N. Fredrickson, andJ.W. Hartley. 1985. Abnormalities in-duced by the mutant gene, Ipr. Patterns of disease and expression of niurine leukemia viruses in SJL/J mice homozygous and heterozygous for Ipr.J. Exp. Mcd. 161:602-616.
18. Andrews, D.S., R.A. Eisenberg, A.N. Theofilopoulos, S. Izui, C.B. Wilson, PJ. McConahey, E.D. Murphy, J.D. Roths, and FJ. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Mcd. 148:1198-1215.
19. Roth, C, C. Rochlitz, and P. Kourilsky. 1994. Immune response against tumors. Adv. Inniniiwl. 57:281-351.
20. Hughes, D.P.M., A. Hayday, J.E. Craft, MJ. Owen, and I.N. Crispe. 1995. T cells with the 7/8 T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-cc-deficient Ipr mice.J. Exp. Mcd. 182:233-241.
21. Retter, M.W., R.A. Eisenberg, P.L. Cohen, and S.H. Clarke. 1995. Sni and DNA binding by dual reactive B cells requires distinct VH, VK, and VH CDR3 structures. J. Iiiiiininol. 155: 2248-2257.
22. Peng, S.L., M.P. Madaio, D.P.M. Hughes, I.N. Crispe, MJ. Owen, L. Wen, A.C. Hayday, andj. Craft. 1996. Murine lupus in the absence of a T cells.J. IiiiiiiniwI. 156:4041-1049.
23. Chu, Y.W., E. Marin, R. Fuleihan, N. Ramesh, F.S. Rosen, R.S. Geha, and R.A. Insel. 1995. Somatic mutation of human immunoglobulin V genes in the X-linked HyperlgM syndrome. J. Clin. Invest. 95:1389-1393.
24. Ferrone, S., and F.M. Marincola. 1995. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Iiiiiniinol. Today. 16: 487-494.
25. Penning-, J.M., T. Wen, E. Timms.J. Potter, V.A. Wallace, T. Matsuyama, D. Ferrick, B. Sydora, M. Kronenberg, and T.W. Mak. 1995. Spontaneous resistance to acute T-cell leukaemias in TCRVyl.lJy4C74 transgenic mice. Nature (Loud.). 375:241-244.
26. Nussenzweig, M.C., E.V. Schmidt, A.C. Shaw, E. Sinn, J. Campos-Torres, B. Mathey-Prevot, P.K. Pattengale, and P. Leder. 1988. A human immunoglobulin gene reduces the incidence of lymphomas in c-iA/yr-bearing transgenic mice. Ar7ntre (Loud.). 336:446-450.
27. Tamura, T., N. Aoyama, H. Saya, H. Haga, S. Futami, M. Miyamoto, T. Koh, T. Ariyasu, M. Tachi, and M. Kasuga. 1995. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oiicogenc. 11:1939-1946.
28. Chiou, S.K., C.C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus El B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cellsj. Virol. 68:6553-6566.
29. Monroe, J.G., and L.E. Silberstein. 1995. HIV-mediated B-lymphocyte activation and lymphomagenesis. J. Clin. Iiniiiuiiol. 15:61-68.